Incyte Aktie

Kaufen

Verkaufen

Incyte Aktien-Sparplan Incyte Aktien-Sparplan

84,78 EUR -0,34 EUR -0,40 %

16:16:46

STU

101,13 USD +0,36 USD +0,36 %

13.02.2026

BTT

Incyte jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.16,95 Mrd. EUR

KGV15,41Div. Rendite0,00%

WKN896133

ISINUS45337C1027

SymbolINCY

Incyte Aktien News

Sortieren:Datum Meistgelesen

29.07.25ZacksIncyte (INCY) Surpasses Q2 Earnings and Revenue Estimates

24.07.25ZacksIncyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?

22.07.25ZacksIncyte (INCY) Earnings Expected to Grow: Should You Buy?

01.07.25ZacksIncyte Gains 9.2% in Three Months: Buy, Hold or Sell the Stock?

19.06.25ZacksIncyte Gets FDA Nod for the Expanded Use of Monjuvi in Lymphoma

17.06.25ZacksIncyte Stock Rises on QIAGEN Deal to Advance Blood Cancer Diagnostics

16.06.25ZacksQGEN Stock Rises in After Market Following Partnership With Incyte

16.06.25BenzingaWhy Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket

03.06.25BenzingaWhere Incyte Stands With Analysts

29.05.25ZacksWhy Is Incyte (INCY) Up 3.6% Since Last Earnings Report?

16.05.25ZacksIncyte Gets FDA Approval for Zynyz in New Cancer Indication

01.05.25Benzinga9 Analysts Have This To Say About Incyte

29.04.25ZacksHere's What Key Metrics Tell Us About Incyte (INCY) Q1 Earnings

29.04.25ZacksIncyte (INCY) Q1 Earnings and Revenues Top Estimates

23.04.25ZacksIncyte Gears Up to Report Q1 Earnings: Here's What You Should Know

22.04.25ZacksIncyte (INCY) Reports Next Week: Wall Street Expects Earnings Growth

21.03.25MotleyFoolWhy Incyte Stock Was Tanking This Week

21.03.25ZacksThe Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics

17.03.25BenzingaIncyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session

12.03.25ZacksIncyte (INCY) Up 2.6% Since Last Earnings Report: Can It Continue?

11.03.25BenzingaIncyte Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

11.03.25BenzingaEli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss

10.03.25BenzingaIncyte Releases Mixed Data From Late-Stage Opzelura Studies In Skin Disease Characterized By Itchy Firm Lumps

08.03.25PR NewswireLilly's baricitinib delivered high rates of hair regrowth for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS study

15.01.25PR NewswireIncyte and Syndax Announce U.S. Food and Drug Administration (FDA) Approval of Niktimvo™ (axatilimab-csfr) 9 mg and 22 mg Vial Sizes

24.07.23PR NewswireSyndax and Incyte Announce Positive Topline Results from the Pivotal AGAVE-201 Trial of Axatilimab in Chronic Graft-Versus-Host Disease

19.04.23PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Incyte Corporation - INCY

07.03.23PR NewswireCaris Life Sciences and Incyte Enter Into Broad Precision Medicine Partnership to Advance Incyte's Oncology Pipeline

03.04.20ReutersNovartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19

03.04.20ReutersRPT-Novartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19

03.04.20ReutersNovartis, Incyte join repurposing wave to give Jakavi a trial run in COVID-19

Incyte News

Incyte News: auf dieser Seite finden Sie alle Incyte News und Nachrichten zur Incyte Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Incyte News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Incyte News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.